Catalyst Wire Dossier Catalyst Wire Dossier

SHR-3167 Injection

SHR-3167 · Jiangsu HengRui Medicine Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SHR-3167 Injection, covering 2026-03-24 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study Comparing the Relative Bioavailability and Safety of SHR-3167 Injection [Phase 1]

See pricing